Papillary neoplasms of the breast: A review

Archives of Pathology and Laboratory Medicine

Volumn 133, Issue 6, 2009, Pages 893-907

  Ueng, Shir Hwa ^a,b,c   Mezzetti, Thomas ^b   Tavassoli, Fattaneh A ^b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ASPIRATION CYTOLOGY; BREAST TUMOR; CANCER GROWTH; CANCER INVASION; CANCER RISK; CLINICAL FEATURE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; NEEDLE BIOPSY; PAPILLOMA; PROGNOSIS; REVIEW;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, PAPILLARY; FEMALE; HUMANS; PAPILLOMA;

EID: 67049115717     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Review

References (87)

1. Papotti M, Gugliotta P, Ghiringhello B, Bussolati G. Association of breast carcinoma and multiple intraductal papillomas: an histological and immunohistochemical investigation. Histopathology. 1984;8(6):963-975. (Pubitemid 15159729)
2. Ohuchi N, Abe R, Takahashi T, Tezuka F. Origin and extension of intraductal papillomas of the breast: a three-dimensional reconstruction study. Breast Cancer Res Treat. 1984;4(2):117-128. (Pubitemid 14078725)
3. Hart D. Intracystic papillomatous tumors of the breast, benign and malignant: analysis of one hundred and twenty-four cases. Arch Surg. 1927;14(4):793-835.
4. Choi YD, Gong GY, Kim MJ, et al. Clinical and cytologic features of papillary neoplasms of the breast. Acta Cytol. 2006;50(1):35-40. (Pubitemid 43157429)
5. Gomez-Aracil V, Mayayo E, Azua J, Arraiza A. Papillary neoplasms of the breast: clues in fine needle aspiration cytology. Cytopathology. 2002;13(1):22-30. (Pubitemid 34415654)
6. Michael CW, Buschmann B. Can true papillary neoplasms of breast and their mimickers be accurately classified by cytology? Cancer. 2002;96(2):92-100. (Pubitemid 34438649)
7. Masood S, Loya A, Khalbuss W. Is core needle biopsy superior to fineneedle aspiration biopsy in the diagnosis of papillary breast lesions? Diagn Cytopathol. 2003;28(6):329-334. (Pubitemid 36682430)
8. Simsir A, Waisman J, Thorner K, Cangiarella J. Mammary lesions diagnosed as "papillary" by aspiration biopsy: 70 cases with follow-up. Cancer. 2003;99(3):156-165.
9. Saad RS, Kanbour-Shakir A, Syed A, Kanbour A. Sclerosing papillary lesion of the breast: a diagnostic pitfall for malignancy in fine needle aspiration biopsy. Diagn Cytopathol. 2006;34(2):114-118. (Pubitemid 43201563)
10. Field A, Mak A. A prospective study of the diagnostic accuracy of cytological criteria in the FNAB diagnosis of breast papillomas. Diagn Cytopathol. 2007;35(8):465-475. (Pubitemid 47267507)
11. Nayar R, De Frias DV, Bourtsos EP, Sutton V, Bedrossian C. Cytologic differential diagnosis of papillary pattern in breast aspirates: correlation with histology. Ann Diagn Pathol. 2001;5(1):34-42. (Pubitemid 32178956)
12. Rosen EL, Bentley RC, Baker JA, Soo MS. Imaging-guided core needle biopsy of papillary lesions of the breast. AJR Am J Roentgenol. 2002;179(5):1185-1192. (Pubitemid 35204371)
13. Renshaw AA, Derhagopian RP, Tizol-Blanco DM, Gould EW. Papillomas and atypical papillomas in breast core needle biopsy specimens: risk of carcinoma in subsequent excision. Am J Clin Pathol. 2004;122(2):217-221. (Pubitemid 38971354)
14. Sydnor MK, Wilson JD, Hijaz TA, Massey HD, Shaw de Paredes ES. Underestimation of the presence of breast carcinoma in papillary lesions initially diagnosed at core-needle biopsy. Radiology. 2007;242(1):58-62. (Pubitemid 44956008)
15. Agoff SN, Lawton TJ. Papillary lesions of the breast with and without atypical ductal hyperplasia: can we accurately predict benign behavior from core needle biopsy? Am J Clin Pathol. 2004;122(3):440-443. (Pubitemid 39145551)
16. Ivan D, Selinko V, Sahin AA, Sneige N, Middleton LP. Accuracy of core needle biopsy diagnosis in assessing papillary breast lesions: histologic predictors of malignancy. Mod Pathol. 2004;17(2):165-171. (Pubitemid 41656512)
17. Rizzo M, Lund MJ, Oprea G, Schniederjan M, Wood WC, Mosunjac M. Surgical follow-up and clinical presentation of 142 breast papillary lesions diagnosed by ultrasound-guided core-needle biopsy [published online ahead of print January 18, 2008]. Ann Surg Oncol. 2008;15(4):1040-1047.
18. Ashkenazi I, Ferrer K, Sekosan M, et al. Papillary lesions of the breast discovered on percutaneous large core and vacuum-assisted biopsies: reliability of clinical and pathological parameters in identifying benign lesions. Am J Surg. 2007;194(2):183-188. (Pubitemid 47001890)
19. Valdes EK, Tartter PI, Genelus-Dominique E, Guilbaud DA, Rosenbaum-Smith S, Estabrook A. Significance of papillary lesions at percutaneous breast biopsy. Ann Surg Oncol. 2006;13(4):480-482.
20. Murad TM, Contesso G, Mouriesse H. Papillary tumors of large lactiferous ducts. Cancer. 1981;48(1):122-133. (Pubitemid 11064388)
21. Woods ER, Helvie MA, Ikeda DM, Mandell SH, Chapel KL, Adler DD. Solitary breast papilloma: comparison of mammographic, galactographic, and pathologic findings. AJR Am J Roentgenol. 1992;159(3):487-491.
22. Carter D. Intraductal papillary tumors of the breast: a study of 78 cases. Cancer. 1977;39(4):1689-1692. (Pubitemid 8107722)
23. Lam WW, Chu WC, Tang AP, Tse G, Ma TK. Role of radiologic features in the management of papillary lesions of the breast. AJR Am J Roentgenol. 2006;186(5):1322-1327. (Pubitemid 46112568)
24. Cardenosa G, Eklund GW. Benign papillary neoplasms of the breast: mammographic findings. Radiology. 1991;181(3):751-755.
25. Han BK, Choe YH, Ko YH, Yang JH, Nam SJ. Benign papillary lesions of the breast: sonographic-pathologic correlation. J Ultrasound Med. 1999;18(3):217-223. (Pubitemid 29104460)
26. Orel SG, Dougherty CS, Reynolds C, Czerniecki BJ, Siegelman ES, Schnall MD. MR imaging in patients with nipple discharge: initial experience. Radiology. 2000;216(1):248-254. (Pubitemid 30434750)
27. Murad TM, Swaid S, Pritchett P. Malignant and benign papillary lesions of the breast. Hum Pathol. 1977;8(4):379-390. (Pubitemid 8159030)
28. MacGrogan G, Tavassoli FA. Central atypical papillomas of the breast: a clinicopathological study of 119 cases. Virchows Arch. 2003;443(5):609-617. (Pubitemid 37500140)
29. Lefkowitz M, Lefkowitz W, Wargotz ES. Intraductal (intracystic) papillary carcinoma of the breast and its variants: a clinicopathological study of 77 cases. Hum Pathol. 1994;25(8):802-809.
30. Page DL, Salhany KE, Jensen RA, Dupont WD. Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma. Cancer. 1996;78(2):258-266. (Pubitemid 26234568)
31. Lewis JT, Hartmann LC, Vierkant RA, et al. An analysis of breast cancer risk in women with single, multiple, and atypical papilloma. Am J Surg Pathol. 2006;30(6):665-672. (Pubitemid 44264991)
32. Collins LC, Schnitt SJ. Papillary lesions of the breast: selected diagnostic and management issues. Histopathology. 2008;52(1):20-29. (Pubitemid 350265188)
33. Gown AM, Vogel AM. Anti-intermediate filament monoclonal antibodies: tissue-specific tools in tumor diagnosis. Surv Synth Pathol Res. 1984;3(5):369-385.
34. Gown AM, Vogel AM. Monoclonal antibodies to human intermediate filament proteins, II: distribution of filament proteins in normal human tissues. Am J Pathol. 1984;114(2):309-321. (Pubitemid 14186855)
35. Gown AM, Vogel AM. Monoclonal antibodies to human intermediate filament proteins, III: analysis of tumors. Am J Clin Pathol. 1985;84(4):413-424. (Pubitemid 16225704)
36. Lacroix-Triki M, Mery E, Voigt JJ, Istier L, Rochaix P. Value of cytokeratin 5/6 immunostaining using D5/16 B4 antibody in the spectrum of proliferative intraepithelial lesions of the breast: a comparative study with 34βE12 antibody. Virchows Arch. 2003;442(6):548-554. (Pubitemid 36819248)
37. Jarasch ED, Nagle RB, Kaufmann M, Maurer C, Bocker WJ. Differential diagnosis of benign epithelial proliferations and carcinomas of the breast using antibodies to cytokeratins. Hum Pathol. 1988;19(3):276-289. (Pubitemid 18099539)
38. Otterbach F, Bankfalvi A, Bergner S, Decker T, Krech R, Boecker W. Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast. Histopathology. 2000;37(3):232-240. (Pubitemid 30695701)
39. Moinfar F, Man YG, Lininger RA, Bodian C, Tavassoli FA. Use of keratin 35βE12 as an adjunct in the diagnosis of mammary intraepithelial neoplasia-ductal type - benign and malignant intraductal proliferations. Am J Surg Pathol. 1999;23(9):1048-1058. (Pubitemid 29409766)
40. Raju U, Crissman JD, Zarbo RJ, Gottlieb C. Epitheliosis of the breast: an immunohistochemical characterization and comparison to malignant intraductal proliferations of the breast. Am J Surg Pathol. 1990;14(10):939-947. (Pubitemid 20317780)
41. Rabban JT, Koerner FC, Lerwill MF. Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6. Hum Pathol. 2006;37(7):787-793. (Pubitemid 43902948)
42. Shah VI, Flowers CI, Douglas-Jones AG, Dallimore NS, Rashid M. Immunohistochemistry increases the accuracy of diagnosis of benign papillary lesions in breast core needle biopsy specimens. Histopathology. 2006;48(6):683-691.
43. Ichihara S, Fujimoto T, Hashimoto K, Moritani S, Hasegawa M, Yokoi T. Double immunostaining with p63 and high-molecular-weight cytokeratins distinguishes borderline papillary lesions of the breast. Pathol Int. 2007;57(3):126-132. (Pubitemid 46239378)
44. Adair FE. Sanguineous discharge from the nipple and its significance in relation to cancer of the breast: a study based on 108 cases. Ann Surg. 1930;91(2):197-209.
45. Estes AC, Phillips C. Papilloma of lacteal duct. Surg Gynecol Obstet. 1949;89(3):345-348.
46. Lewison EF, Lyons JG Jr. Relationship between benign breast disease and cancer. AMA Arch Surg. 1953;66(1):94-114.
47. Haagensen CD. Diseases of the Breast. 3rd ed. Philadelphia, PA: Saunders; 1986:xiii.
48. Haagensen CD, Stout AP, Phillips JS. The papillary neoplasms of the breast, I: benign intraductal papilloma. Ann Surg. 1951;133(1):18-36.
49. Ciatto S, Andreoli C, Cirillo A, et al. The risk of breast cancer subsequent to histologic diagnosis of benign intraductal papilloma follow-up study of 339 cases. Tumori. 1991;77(1):41-43.
50. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985;312(3):146-151. (Pubitemid 15192861)
51. Pellettiere EV II. The clinical and pathologic aspects of papillomatous disease of the breast: a follow-up study of 97 patients treated by local excision. Am J Clin Pathol. 1971;55(6):740-748.
52. Ali-Fehmi R, Carolin K, Wallis T, Visscher DW. Clinicopathologic analysis of breast lesions associated with multiple papillomas. Hum Pathol. 2003;34(3):234-239. (Pubitemid 36356675)
53. Ohuchi N, Abe R, Kasai M. Possible cancerous change of intraductal papillomas of the breast: a 3-D reconstruction study of 25 cases. Cancer. 1984;54(4):605-611. (Pubitemid 14060336)
54. Raju U, Vertes D. Breast papillomas with atypical ductal hyperplasia: a clinicopathologic study. Hum Pathol. 1996;27(11):1231-1238. (Pubitemid 26374946)
55. Tan PH, Aw MY, Yip G, et al. Cytokeratins in papillary lesions of the breast: is there a role in distinguishing intraductal papilloma from papillary ductal carcinoma in situ? Am J Surg Pathol. 2005;29(5):625-632. (Pubitemid 40577872)
56. Carter D, Orr SL, Merino MJ. Intracystic papillary carcinoma of the breast: after mastectomy, radiotherapy or excisional biopsy alone. Cancer. 1983;52(1):14-19.
57. Gatchell FG, Dockerty MB, Clagett OT. Intracystic carcinoma of the breast. Surg Gynecol Obstet. 1958;106(3):347-352.
58. Hill CB, Yeh IT. Myoepithelial cell staining patterns of papillary breast lesions: from intraductal papillomas to invasive papillary carcinomas. Am J Clin Pathol. 2005;123(1):36-44. (Pubitemid 40068840)
59. Collins LC, Carlo VP, Hwang H, Barry TS, Gown AM, Schnitt SJ. Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers. Am J Surg Pathol. 2006;30(8):1002-1007. (Pubitemid 44264950)
60. Nicolas MM, Wu Y, Middleton LP, Gilcrease MZ. Loss of myoepithelium is variable in solid papillary carcinoma of the breast. Histopathology. 2007;51(5):657-665. (Pubitemid 47572874)
61. Nassar H, Qureshi H, Volkanadsay N, Visscher D. Clinicopathologic analysis of solid papillary carcinoma of the breast and associated invasive carcinomas. Am J Surg Pathol. 2006;30(4):501-507. (Pubitemid 43740152)
62. Mulligan AM, O'Malley FP. Metastatic potential of encapsulated (intracystic) papillary carcinoma of the breast: a report of 2 cases with axillary lymph node micrometastases. Int J Surg Pathol. 2007;15(2):143-147. (Pubitemid 46548101)
63. Solorzano CC, Middleton LP, Hunt KK, et al. Treatment and outcome of patients with intracystic papillary carcinoma of the breast. Am J Surg. 2002;184(4):364-368. (Pubitemid 35287362)
64. Maluf HM, Koerner FC. Solid papillary carcinoma of the breast: a form of intraductal carcinoma with endocrine differentiation frequently associated with mucinous carcinoma. Am J Surg Pathol. 1995;19(11):1237-1244.
65. Otsuki Y, Yamada M, Shimizu S, et al. Solid-papillary carcinoma of the breast: clinicopathological study of 20 cases. Pathol Int. 2007;57(7):421-429. (Pubitemid 46976409)
66. Fisher ER, Palekar AS, Redmond C, Barton B, Fisher B. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4), VI: invasive papillary cancer. Am J Clin Pathol. 1980;73(3):313-322. (Pubitemid 10124564)
67. Dixon JM, Page DL, Anderson TJ, et al. Long-term survivors after breast cancer. Br J Surg. 1985;72(6):445-448. (Pubitemid 15022827)
68. McDivitt RW, Holleb AI, Foote FW Jr. Prior breast disease in patients treated for papillary carcinoma. Arch Pathol. 1968;85(2):117-124.
69. Youngson BJ, Cranor M, Rosen PP. Epithelial displacement in surgical breast specimens following needling procedures. Am J Surg Pathol. 1994;18(9):896-903. (Pubitemid 24260229)
70. Youngson BJ, Liberman L, Rosen PP. Displacement of carcinomatous epithelium in surgical breast specimens following stereotaxic core biopsy. Am J Clin Pathol. 1995;103(5):598-602.
71. Nagi C, Bleiweiss I, Jaffer S. Epithelial displacement in breast lesions: a papillary phenomenon. Arch Pathol Lab Med. 2005;129(11):1465-1469. (Pubitemid 41587022)
72. Siriaunkgul S, Tavassoli FA. Invasive micropapillary carcinoma of the breast. Mod Pathol. 1993;6(6):660-662. (Pubitemid 2014261)
73. Tavassoli FA, Devilee P. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon, France: IARC Press; 2003. World Health Organization Classification of Tumours; vol 4.
74. Walsh MM, Bleiweiss IJ. Invasive micropapillary carcinoma of the breast: eighty cases of an underrecognized entity. Hum Pathol. 2001;32(6):583-589. (Pubitemid 32601239)
75. Nassar H, Wallis T, Andea A, Dey J, Adsay V, Visscher D. Clinicopathologic analysis of invasive micropapillary differentiation in breast carcinoma. Mod Pathol. 2001;14(9):836-841. (Pubitemid 32889240)
76. Pettinato G, Manivel CJ, Panico L, Sparano L, Petrella G. Invasive micropapillary carcinoma of the breast: clinicopathologic study of 62 cases of a poorly recognized variant with highly aggressive behavior. Am J Clin Pathol. 2004;121(6):857-866. (Pubitemid 38669280)
77. Luna-More S, Casquero S, Perez-Mellado A, Rius F, Weill B, Gornemann I. Importance of estrogen receptors for the behavior of invasive micropapillary carcinoma of the breast: review of 68 cases with follow-up of 54. Pathol Res Pract. 2000;196(1):35-39. (Pubitemid 30046524)
78. Ling C, Yu F, Lang RG, et al. Breast carcinoma with micropapillary features: clinicopathologic study and long-term follow-up of 100 cases. Int J Surg Pathol. 2008;16(2):155-163. (Pubitemid 351549762)
79. Gunhan-Bilgen I, Zekioglu O, Ustun EE, Memis A, Erhan Y. Invasive micropapillary carcinoma of the breast: clinical, mammographic, and sonographic findings with histopathologic correlation. AJR Am J Roentgenol. 2002;179(4):927-931.
80. Paterakos M, Watkin WG, Edgerton SM, Moore DH II, Thor AD. Invasive micropapillary carcinoma of the breast: a prognostic study. Hum Pathol. 1999;30(12):1459-1463. (Pubitemid 30032922)
81. Middleton LP, Tressera F, Sobel ME, et al. Infiltrating micropapillary carcinoma of the breast. Mod Pathol. 1999;12(5):499-504. (Pubitemid 29230611)
82. Nassar H, Pansare V, Zhang H, et al. Pathogenesis of invasive micropapillary carcinoma: role of MUC1 glycoprotein. Mod Pathol. 2004;17(9):1045-1050. (Pubitemid 39128230)
83. Li YS, Kaneko M, Sakamoto DG, Takeshima Y, Inai K. The reversed apical pattern of MUC1 expression is characteristics of invasive micropapillary carcinoma of the breast. Breast Cancer. 2006;13(1):58-63.
84. Zekioglu O, Erhan Y, Ciris M, Bayramoglu H, Ozdemir N. Invasive micropapillary carcinoma of the breast: high incidence of lymph node metastasis with extranodal extension and its immunohistochemical profile compared with invasive ductal carcinoma. Histopathology. 2004;44(1):18-23. (Pubitemid 38174865)
85. De la Cruz C, Moriya T, Endoh M, et al. Invasive micropapillary carcinoma of the breast: clinicopathological and immunohistochemical study. Pathol Int. 2004;54(2):90-96. (Pubitemid 38979630)
86. Kim MJ, Gong G, Joo HJ, Ahn SH, Ro JY. Immunohistochemical and clinicopathologic characteristics of invasive ductal carcinoma of breast with micropapillary carcinoma component. Arch Pathol Lab Med. 2005;129(10):1277-1282. (Pubitemid 41407433)
87. Thor AD, Eng C, Devries S, et al. Invasive micropapillary carcinoma of the breast is associated with chromosome 8 abnormalities detected by comparative genomic hybridization. Hum Pathol. 2002;33(6):628-631. (Pubitemid 34827544)